OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has successfully raised $7 million through a placement to advance its commercialization efforts and clinical trials, alongside a $1 million share purchase plan for eligible shareholders. The funds will be used to enhance market penetration in existing regions and support expansion into new markets like Switzerland and South Korea. This financial boost aims to increase the adoption of OncoSil’s medical devices.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
